Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Propanc Biopharma, Inc. highlights new preclinical data demonstrating that its lead candidate PRP achieves over 90% tumor growth inhibition and more than 2.5-fold survival benefit in pancreatic ductal adenocarcinoma (PDAC) models. PRP works by promoting cancer cell differentiation and reversing mechanisms like EMT and cancer stem cell presence, whi…
SAB Biotherapeutics, a clinical-stage biopharmaceutical company listed on Nasdaq (SABS), announced multiple presentations featuring their lead candidate SAB-142 at the 62nd European Association for the Study of Diabetes meeting. SAB-142 is a novel, human anti-thymocyte immunoglobulin therapy showing potential to modify disease progression in Stage …
Fiserv announces that its Clover commerce platform has been selected by the Winnipeg Blue Bombers to manage commerce operations at their stadium, marking a significant expansion of Fiserv's presence in Canada’s sports, entertainment, and hospitality sectors. Clover supports multiple Canadian Football League venues and offers integrated payment proc…
Natural gas strength and accelerating LNG exports underpin Cheniere’s cash flow, but the stock has pulled back into a reasonable buy zone. With a market cap near $56.8B, stable free cash flow and constructive contract-backed volumes, this is a buy-the-dip swing trade with disciplined stops and a clear catalyst calendar.
Societe Generale's Capital Markets Day on 09/21/2026 largely confirmed the bank's prior strategy: cost control, gradual capital returns and incremental de-risking. Management offered no materially new levers to accelerate return on tangible equity or earnings growth. That leaves the stock exposed to a re-rating if macro momentum stalls or investors…
Bank of America analysts have lifted their Brent crude price projection for the second half of 2026 to $95 a barrel from $83, citing sustained geopolitical tensions and notable disruptions to key oil chokepoints. The bank highlights sharply reduced flows through the Strait of Hormuz, alternative route constraints, and clashes at the Bab el-Mandeb a…
A senior Iranian official said Iran could reopen the Strait of Hormuz to Gulf shipping within days if the United States removes its blockade, describing upcoming United Nations meetings as a key chance to renew diplomacy. With both presidents expected at the UN General Assembly, Tehran says its delegation has authority to restart talks and has tran…
Scienture Holdings, Inc. announced an exclusive sales, marketing, and distribution agreement to distribute its FDA-approved REZENOPY™ naloxone hydrochloride nasal spray through a partner's network of approximately 2,000 Opioid Treatment Program (OTP) clinics and addiction treatment centers across the United States. The agreement complements Scientu…
Xenon Pharmaceuticals' lead candidate azetukalner posted convincing Phase 3 seizure reductions and an NDA was submitted 09/18/2026. The stock has sold off after a temporary pause in depression studies, creating a volatile entry point. This trade idea lays out a mid-term swing (45 trading days) long with a clear entry, stop and target while framing …
TriplePoint Venture Growth (TPVG) trades at a heavy discount to book with a published quarterly distribution of $0.29 and a cited yield near 19%. Balance-sheet leverage and short interest create volatility, but low valuation multiples (P/E ~6, P/B ~0.56) and positive free cash flow give upside to shareholders who collect the payout and wait for NAV…
Top Wealth Group Holding Limited, a NASDAQ-listed premium caviar and wine supplier, announced the relocation of its global headquarters from Hong Kong to Lille, France. This strategic move supports the company's shift from a regional Asian focus to a wider global luxury food and beverage market presence. The relocation aims to enhance distribution …
IMUNON's DNA-based immunotherapy candidate IMNN-001 demonstrated a favorable safety profile with no serious immune-related adverse events in an ongoing Phase 2 minimal residual disease (MRD) study for advanced ovarian cancer. The Independent Data Monitoring Committee recommended continuation without modifications, validating the drug's tolerability…
Enlivex Ltd. announced the termination of a previously agreed securities purchase agreement with the Rain Foundation, under which it planned a private placement of ordinary shares payable in RAIN tokens. The termination means the company will not proceed with the private placement nor seek shareholder approval. Enlivex combines clinical-stage immun…
Marker Therapeutics highlights enhanced manufacturing support for its lead immuno-oncology program MT-601 following the combination of its CDMO partner Cellipont Bioservices with Kincell Bio to form Kincellis Advanced Therapies. This expanded U.S.-based organization offers broader infrastructure and expertise to support late-stage clinical developm…
Smith+Nephew announced FDA 510(k) clearance for its LANDMARK Total Knee System, a next-generation knee replacement designed to replicate healthy knee anatomy and support personalized knee arthroplasty. The company has completed first surgical cases and plans a phased commercial launch starting with early adopters and broader availability in 2027.
Swvl Holdings Corp announces the launch of a 24/7 shuttle service in Madinah, Saudi Arabia, connecting seven hotels to Al-Masjid an-Nabawi and key city landmarks. This initiative deepens Swvl's presence in the Kingdom of Saudi Arabia, targeting the high-demand pilgrimage transport segment with technology-enabled mass mobility solutions. The move al…
XFLH Capital Corporation, a publicly traded special purpose acquisition company (SPAC), announced it has signed a non-binding letter of intent to pursue a business combination with Renogen Biolab Inc., a Canadian health service provider specializing in molecular capabilities such as DNA services, vector engineering, and protein expression. The comp…
FactSet has acquired BCC Group International, a specialist in cloud-native market data distribution platforms, to enhance its Real-Time Solution Suite. This acquisition aims to provide clients with more flexible, open, and modular market data infrastructure solutions, addressing the evolving needs of trading, AI workflows, and regulatory compliance…
Mixed Martial Arts Group Limited (NYSE American: MMA), operating as MMA.INC, announced the pre-sale for its next cycle of the TrainAlta Warrior Training Program at 27 UFC GYM locations across seven states. This cycle, commencing November 9, 2026, represents an approximate 29% increase in locations over the current cycle, expanding into Tennessee an…
Adagene announced that China's National Medical Products Administration (NMPA) has approved its IND application for ADG138, a novel double-masked HER2xCD3 bispecific T-cell engager designed with proprietary SAFEbody technology to selectively target HER2-expressing tumors with reduced systemic toxicity. The company plans to initiate a Phase 1 study …
Clene Inc., a late-stage biopharmaceutical company focused on mitochondrial health therapies for neurodegenerative diseases, announced its participation in the 5th Annual ROTH Healthcare Opportunities Conference and the Lytham Partners Investor Conference Fall Event on September 29-30, 2026. Management will conduct one-on-one investor meetings and …
SCYNEXIS, a NASDAQ-listed clinical-stage biotech company focused on rare diseases, announced the appointment of Steven K. Burke, M.D., an experienced industry veteran in chronic kidney disease drug development, to its Board of Directors. His expertise supports the company’s advancement of SCY-770, a promising drug candidate for Autosomal Dominant P…
Rhythm Pharmaceuticals announced Health Canada’s approval of IMCIVREE® (setmelanotide) for managing weight in adult and pediatric patients aged 4 and older with acquired hypothalamic obesity (HO). This indication expansion follows successful Phase 3 trial results showing significant BMI reduction. IMCIVREE is a first-in-class MC4R agonist targeting…
AgEagle Aerial Systems Inc., trading as EagleNXT (NYSE: UAVS), announced that its Allen, Texas headquarters is now shipping domestically-produced eBee VISION ISR drones and the newly released MicaSense RedEdge-MX multispectral sensors. The company recently fulfilled a key order delivering nine eBee VISION kits to the U.S. Army's National Training C…
Algorhythm Holdings, Inc. (NASDAQ: RIME) announced its strategic priorities focusing on building recurring profitable revenue through its AI-driven logistics segment SemiCab and renewable energy developer Azure Energy. Management plans to reduce SemiCab's operating losses and pursue capital-efficient partnerships, while leveraging Azure's $10M+ con…
